当前位置:首页 - 行情中心 - 我武生物(300357) - 财务分析

我武生物

(300357)

  

流通市值:118.51亿  总市值:128.23亿
流通股本:4.84亿   总股本:5.24亿

我武生物(300357)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.17亿元,每股收益0.23元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益282722.58万元,未分配利润181616.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产293626.26万元,负债10903.67万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入252,840,950.041,062,404,471.43853,360,357.81484,236,510.36
营业总成本149,929,001.8635,510,347.27459,695,071.95288,042,152.3
其他经营收益
营业利润133,093,069.95438,417,461.01397,697,295.47201,360,980.09
利润总额131,783,306.64432,705,375394,278,352.77199,529,092.8
净利润116,512,634.85368,089,245.89335,236,989.97170,429,226.33
每股收益
其他综合收益-6,064.56-6,986.28-4,046.55-4,365.07
综合收益总额116,506,570.29368,082,259.61335,232,943.42170,424,861.26
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,764,421,583.531,761,246,105.521,772,325,445.941,683,562,028.46
非流动资产:
非流动资产合计1,171,840,975.021,136,148,176.161,120,888,431.31,106,515,013.98
资产总计2,936,262,558.552,897,394,281.682,893,213,877.242,790,077,042.44
流动负债:
流动负债合计67,506,994.4144,573,973.66119,952,859.31180,196,275.95
非流动负债:
非流动负债合计41,529,735.641,096,853.0642,028,479.1643,456,309.88
负债合计109,036,730185,670,826.72161,981,338.47223,652,585.83
所有者权益(或股东权益):
归属于母公司股东权益合计2,738,678,3102,619,452,220.072,635,739,108.732,467,880,978.57
股东权益合计2,827,225,828.552,711,723,454.962,731,232,538.772,566,424,456.61
负债和股东权益合计2,936,262,558.552,897,394,281.682,893,213,877.242,790,077,042.44
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计230,408,095.321,134,097,422.33870,623,729.48529,161,653.65
经营活动现金流出小计175,358,955.76710,901,675.72583,732,651.97328,645,801.55
经营活动产生的现金流量净额55,049,139.56423,195,746.61286,891,077.51200,515,852.1
投资活动产生的现金流量:
投资活动现金流入小计304,589,685.881,105,085,213.76744,697,126.87453,032,942.81
投资活动现金流出小计260,490,025.841,376,963,923.14894,953,324.95587,133,109.04
投资活动产生的现金流量净额44,099,660.04-271,878,709.38-150,256,198.08-134,100,166.23
筹资活动产生的现金流量:
筹资活动现金流入小计5,000,00020,000,00020,000,00015,000,000
筹资活动现金流出小计58,932,425.46149,109,173.84147,817,678.5378,482,286.35
筹资活动产生的现金流量净额-53,932,425.46-129,109,173.84-127,817,678.53-63,482,286.35
汇率变动对现金及现金等价物的影响-6,424.71-7,171.42-4,046.21-4,641.7
现金及现金等价物净增加额45,209,949.4322,200,691.978,813,154.692,928,757.82
期末现金及现金等价物余额165,272,928.21120,062,978.78106,675,441.5100,791,044.63
补充资料:
现金及现金等价物的净增加额-22,200,691.97-2,928,757.82
最新报告期:2026-05-15
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中泰证券祝嘉琦0.871.021.192026-05-15
兴业证券东楠,孙媛媛,黄翰漾0.860.991.152026-05-12
国泰海通彭娉,郑琴,余文心0.860.991.202026-04-30
开源证券阮帅,余汝意0.861.041.242026-04-27
TOP↑